Assignment of Assignor's Interest

Recorded: 2014-06-10 Pages: 5

Assignor

THERAVANCE, INC.

Executed: 2014-06-01

Assignee

THERAVANCE BIOPHARMA R&D IP, LLC

901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080

Covered Properties (5)

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 7,728,144 →

Application: 11/451,179 →

Publication: US 2006/0281740

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 8,013,152 →

Application: 12/759,887 →

Publication: US 2010/0197667

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 8,119,796 →

Application: 13/193,874 →

Publication: US 2011/0281851

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 8,399,488 →

Application: 13/348,085 →

Publication: US 2012/0122850

Biphenyl compounds useful as muscarinic receptor antagonists

Application: 60/690,008 →

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.